专业监测看板

Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABP

药物 / 成分：Cefepime-taniborbactam、Meropenem

登记的停止原因（原文）：Study suspended

Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC

药物 / 成分：certepetide、nab-paclitaxel、gemcitabine、placebo matching certepetide

登记的停止原因（原文）：Management Decision

Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma)

药物 / 成分：Recombinant Hepatitis B new Bulk vaccine、DTP-HB-Hib with Recombinant Hepatitis B new Bulk vaccine、Recombinant Hepatitis B vaccine (Registered BioFarma)、Pentabio

登记的停止原因（原文）：The products will be replace with others.

Efficacy & Safety for LN144 With Pembrolizumab With High Risk Stage IIIb-dResectable Melanoma

药物 / 成分：LN-144、Cyclophosphamide、Mesna、Fludarabine

登记的停止原因（原文）：Iovance withdrew support due to length of time required to meet accrual goal.

Optimizing Microdosing and Meditation

药物 / 成分：Psilocybin、Meditation

登记的停止原因（原文）：No funding was obtained.

A Study to Investigate the Sequencing Strategy of Pirtobrutinib After Disease Progression on First-line Acalabrutinib Treatment for Adult Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

药物 / 成分：Pirtobrutinib、Acalabrutinib

登记的停止原因（原文）：AstraZeneca has made the decision to cancel the trial.

Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer

药物 / 成分：PG2、Placebo

登记的停止原因（原文）：Study reevaluation

DM199 for Pregnancy Complications

药物 / 成分：DM199

登记的停止原因（原文）：This entry was unauthorized and has been withdrawn.

Study of Airway Inflammatory Responses to Experimental Rhinovirus Infection

药物 / 成分：RG-HRV16

登记的停止原因（原文）：Suspended due to COVID-19. Protocol did not resume post COVID due to funding.

Multimodal Pain Package vs. Regular Formulation for Pain Management in Ambulatory Spinal Surgery

药物 / 成分：Acetaminophen、Celebrex、Gabapentin、Famotidine

登记的停止原因（原文）：Study drug was not compliant with research pharmacy

Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian Cancer

药物 / 成分：Bevacizumab、Biospecimen Collection、Computed Tomography、Magnetic Resonance Imaging

登记的停止原因（原文）：Other - Protocol moved to Withdrawn

Daunorubicin, Cytarabine Liposomes Plus Venetoclax vs Azacitidine Plus Venetoclax in AML Patients Unfit for Intensive Chemotherapy

药物 / 成分：daunorubicin, cytarabine liposomes、Azacitidine、Venetoclax

登记的停止原因（原文）：The project was terminated as the genetic office did not approve it.

Study of Two Dose Levels of RTA 402 in Patients With Advanced Malignant Melanoma

药物 / 成分：RTA 402 Dose1、RTA 402 Dose2

HEMolysis in a Percutaneous Axial Flow LVAD, Effects of Pentoxifylline in a Randomized Controlled Trial

药物 / 成分：Pentoxifylline Oral Product、Placebo

登记的停止原因（原文）：Initially the study was underfunded; then, the device we planned to use was changed and the new pump significantly reduced hemolysis.

Medications After Adolescent Bariatric Surgery

药物 / 成分：Topiramate、Phentermine

登记的停止原因（原文）：No available funding

Efficacy of Decitabine in Clearance of MRD

药物 / 成分：Decitabine

登记的停止原因（原文）：No participants enrolled

Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) in Healthy Pregnant Women

药物 / 成分：TURKOVAC

登记的停止原因（原文）：the clinical trial did not initiated

Pilot Assessment of the Effects of Bardoxolone Methyl on Renal Perfusion, Systemic Haemodynamics and Cardiac Function in Patients With Chronic Kidney Disease and Type 2 Diabetes

药物 / 成分：Bardoxolone Methyl

登记的停止原因（原文）：IDMC recommendation for safety concerns

A Double-Blind, Randomized, Placebo-Controlled Safety Study Evaluating the Effects of Residual Renal Function (RFF) in Patients With End-Stage Renal Disease and Type 2 Diabetes Mellitus on Peritoneal Dialysis

药物 / 成分：Bardoxolone Methyl 20 mg、Placebo

登记的停止原因（原文）：IDMC recommendation for safety concerns

A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Effects of Bardoxolone Methyl on Body Composition in Patients With Stage 4 Chronic Kidney Disease and Type 2 Diabetes Mellitus

药物 / 成分：Bardoxolone Methyl、Placebo

登记的停止原因（原文）：IDMC recommendation for safety concerns